Position in ABBV
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$9,813
-$191 QoQ
Shares Held
39
-15.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#4,125
of 4,153 holders
Holding Since
Mar 2023
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Imprint Wealth LLC holds $212,027 across 8 Drug Manufacturers - General names. ABBV ranks #4 (4.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
91 | $109,148 | |
| 2 | JNJ |
Johnson & Johnson
|
195 | $49,524 | |
| 3 | NVS |
Novartis AG
|
150 | $23,508 | |
| 4 | ABBV |
AbbVie Inc.
This page
|
39 | $9,813 | |
| 5 | MRK |
Merck & Co., Inc.
|
48 | $6,168 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
45 | $5,685 | |
| 7 | AZN |
Astrazeneca PLC
|
22 | $4,171 | |
| 8 | SNY |
Sanofi
|
94 | $4,010 |
All Filings in ABBV
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,813 | 39 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $10,004 | 46 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $28,561 | 125 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $18,523 | 80 | Shares | Sole | 2025-11-14 | |
| 2024-03-31 | $3,955,576 | 21,722 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $2,548,636 | 16,446 | Shares | Sole | 2024-01-30 | |
| 2023-09-30 | $2,443,838 | 16,395 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $2,127,925 | 15,794 | Shares | Sole | 2023-08-17 | |
| 2023-03-31 | $2,703,712 | 16,965 | Shares | Sole | 2023-05-15 | |
| No filing history on record for this holder in this stock. | ||||||